<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(1)</volume><submitter>Sumithra B</submitter><pubmed_abstract>Human KHDRBS1/Sam68 is an oncogenic splicing factor involved in signal transduction and pre-mRNA splicing. We explored the molecular mechanism of KHDRBS1 to be a prognostic marker in four different cancers. Within specific cancer, including kidney renal papillary cell carcinoma (KIRP), lung adenocarcinoma (LUAD), acute myeloid leukemia (LAML), and ovarian cancer (OV), KHDRBS1 expression is heterogeneous and patient specific. In KIRP and LUAD, higher expression of KHDRBS1 affects the patient survival, but not in LAML and OV. Genome-wide coexpression analysis reveals genes and transcripts which are coexpressed with KHDRBS1 in KIRP and LUAD, form the functional modules which are majorly involved in cancer-specific events. However, in case of LAML and OV, such modules are absent. Irrespective </pubmed_abstract><journal>Scientific reports</journal><pagination>11083</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6668649</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A comprehensive study on genome-wide coexpression network of KHDRBS1/Sam68 reveals its cancer and patient-specific association.</pubmed_title><pmcid>PMC6668649</pmcid><pubmed_authors>Saxena U</pubmed_authors><pubmed_authors>Sumithra B</pubmed_authors><pubmed_authors>Das AB</pubmed_authors></additional><is_claimable>false</is_claimable><name>A comprehensive study on genome-wide coexpression network of KHDRBS1/Sam68 reveals its cancer and patient-specific association.</name><description>Human KHDRBS1/Sam68 is an oncogenic splicing factor involved in signal transduction and pre-mRNA splicing. We explored the molecular mechanism of KHDRBS1 to be a prognostic marker in four different cancers. Within specific cancer, including kidney renal papillary cell carcinoma (KIRP), lung adenocarcinoma (LUAD), acute myeloid leukemia (LAML), and ovarian cancer (OV), KHDRBS1 expression is heterogeneous and patient specific. In KIRP and LUAD, higher expression of KHDRBS1 affects the patient survival, but not in LAML and OV. Genome-wide coexpression analysis reveals genes and transcripts which are coexpressed with KHDRBS1 in KIRP and LUAD, form the functional modules which are majorly involved in cancer-specific events. However, in case of LAML and OV, such modules are absent. Irrespective </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2026-04-29T03:44:06.234Z</modification><creation>2019-08-28T07:01:54Z</creation></dates><accession>S-EPMC6668649</accession><cross_references><pubmed>31366900</pubmed><doi>10.1038/s41598-019-47558-x</doi></cross_references></HashMap>